Gambia vs Morocco: Antiretroviral therapy coverage for PMTCT
Gambia
77.0%
in 2024
Morocco
72.0%
in 2024
Gambia rank
46th
Morocco rank
49th
Antiretroviral therapy coverage for PMTCT over time
- Gambia
- Morocco
How they compare
Gambia currently reports 77.0% against 72.0% in Morocco, a difference of 5.0%.
That makes Gambia's figure about 1.1 times Morocco's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Morocco ahead.
Gambia ranks 46th and Morocco ranks 49th of 84 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.6% | 3.9% | 7.7% | Gambia |
| 2010s | 63.1% | 34.4% | 28.7% | Gambia |
| 2020s | 73.2% | 55.8% | 17.4% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Gambia or Morocco?
- Gambia, at 77.0% against 72.0% in Morocco as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Gambia and Morocco?
- 5.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Morocco?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Morocco rank globally for antiretroviral therapy coverage for pmtct?
- Gambia ranks 46th and Morocco ranks 49th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).